Although others have studied the prognostic effect of WT1 at diagnosis in patients with AML, the results are controversial; some studies reported that high WT1 transcript levels were associated with a good outcome [20–22], and others reported the contrary [23–26]. The gene discussed is WT1; the disease is acute myeloid leukemia.